Schöpf E - Search Results

1

Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis.

Kapp A, Piskorski A, Schöpf E. Kapp A, et al. Among authors: schopf e. Br J Dermatol. 1988 Dec;119(6):707-10. doi: 10.1111/j.1365-2133.1988.tb03491.x. Br J Dermatol. 1988. PMID: 3264510

2

Production of interferon and lymphoproliferative response in whole blood cultures derived from patients with atopic dermatitis.

Kapp A, Gillitzer R, Kirchner H, Schöpf E. Kapp A, et al. Among authors: schopf e. Arch Dermatol Res. 1987;279 Suppl:S55-8. doi: 10.1007/BF00585921. Arch Dermatol Res. 1987. PMID: 3116950

3

IgE autoantibodies in atopic dermatitis--occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE.

Czech W, Stadler BM, Schôpf E, Kapp A. Czech W, et al. Among authors: schopf e. Allergy. 1995 Mar;50(3):243-8. doi: 10.1111/j.1398-9995.1995.tb01141.x. Allergy. 1995. PMID: 7545880

4

Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity.

Czech W, Schöpf E, Kapp A. Czech W, et al. Among authors: schopf e. Br J Dermatol. 1996 Jan;134(1):17-21. Br J Dermatol. 1996. PMID: 8745880 Clinical Trial.

5

High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.

Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sönnichsen N, Czech W, Kapp A, Stege H, Grewe M, Schöpf E. Krutmann J, et al. Among authors: schopf e. J Am Acad Dermatol. 1998 Apr;38(4):589-93. doi: 10.1016/s0190-9622(98)70123-9. J Am Acad Dermatol. 1998. PMID: 9555799 Clinical Trial.

6

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.

Reitamo S, Wollenberg A, Schöpf E, Perrot JL, Marks R, Ruzicka T, Christophers E, Kapp A, Lahfa M, Rubins A, Jablonska S, Rustin M. Reitamo S, et al. Among authors: schopf e. Arch Dermatol. 2000 Aug;136(8):999-1006. doi: 10.1001/archderm.136.8.999. Arch Dermatol. 2000. PMID: 10926735 Clinical Trial.

7

High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.

Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. Krutmann J, et al. Among authors: schopf e. J Am Acad Dermatol. 1992 Feb;26(2 Pt 1):225-30. doi: 10.1016/0190-9622(92)70031-a. J Am Acad Dermatol. 1992. PMID: 1552057 Clinical Trial.

8

Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.

Czech W, Krutmann J, Schöpf E, Kapp A. Czech W, et al. Among authors: schopf e. Br J Dermatol. 1992 Apr;126(4):351-5. doi: 10.1111/j.1365-2133.1992.tb00677.x. Br J Dermatol. 1992. PMID: 1571256

9

Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.

Kapp A, Neuner P, Krutmann J, Luger TA, Schöpf E. Kapp A, et al. Among authors: schopf e. Acta Derm Venereol. 1991;71(5):403-6. Acta Derm Venereol. 1991. PMID: 1684468

10

Eosinophil cationic protein in sera of patients with atopic dermatitis.

Kapp A, Czech W, Krutmann J, Schöpf E. Kapp A, et al. Among authors: schopf e. J Am Acad Dermatol. 1991 Apr;24(4):555-8. doi: 10.1016/0190-9622(91)70081-c. J Am Acad Dermatol. 1991. PMID: 2033129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters